Published in J Virol on December 01, 1990
Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol (1995) 2.06
Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol (1997) 1.96
Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol (1993) 1.64
Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon. J Virol (1997) 1.24
Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J Virol (1991) 1.22
CD8+ T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in mice. J Virol (1997) 1.21
Rotavirus vaccines: an overview. Clin Microbiol Rev (1996) 1.19
Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities. J Virol (1997) 1.13
Vaccines for mucosal immunity to combat emerging infectious diseases. Emerg Infect Dis (2000) 1.11
In vivo role of lymphocyte subpopulations in the control of virus excretion and mucosal antibody responses of cattle infected with rotavirus. J Virol (1993) 1.10
Expression of the mucosal homing receptor alpha4beta7 correlates with the ability of CD8+ memory T cells to clear rotavirus infection. J Virol (1998) 1.07
Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay. J Virol (2005) 1.01
VP7 and VP4 genotyping of human group A rotavirus in Buenos Aires, Argentina. J Clin Microbiol (2000) 0.99
Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. J Virol (2006) 0.93
Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus. J Virol (1991) 0.92
Protective immunity to rotavirus shedding in the absence of interleukin-6: Th1 cells and immunoglobulin A develop normally. J Virol (2000) 0.86
Why does the world need another rotavirus vaccine? Ther Clin Risk Manag (2008) 0.83
Synthesis of an HIV-1 Tat transduction domain-rotavirus enterotoxin fusion protein in transgenic potato. Plant Cell Rep (2003) 0.79
B-Cell-Deficient and CD8 T-Cell-Depleted Gnotobiotic Pigs for the Study of Human Rotavirus Vaccine-Induced Protective Immune Responses. Viral Immunol (2016) 0.75
IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol (1980) 10.30
Cytotoxic T-cell immunity to influenza. N Engl J Med (1983) 8.49
Properties and applications of monoclonal antibodies directed against determinants of they Thy-1 locus. J Immunol (1979) 7.79
Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med (1976) 7.57
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med (1982) 5.72
CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol (1987) 4.58
A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh. J Infect Dis (1980) 3.96
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17
Analysis of the effector functions of different populations of mucosal lymphocytes. Ann N Y Acad Sci (1983) 2.31
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21
Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia. J Immunol (1981) 2.19
Homing receptors and vascular addressins: cell adhesion molecules that direct lymphocyte traffic. Immunol Rev (1989) 2.06
Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J Virol (1985) 2.06
Response of mice to rotaviruses of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation, and plaque reduction neutralization. Infect Immun (1983) 2.06
Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis (1988) 1.97
A murine model for oral infection with a primate rotavirus (simian SA11). J Virol (1984) 1.91
Cultivation and characterization of three strains of murine rotavirus. J Virol (1986) 1.90
Intraepithelial lymphocytes of human gut: isolation, characterisation and study of natural killer activity. Gut (1985) 1.76
Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. J Virol (1990) 1.51
Murine intestinal intraepithelial lymphocytes I. Relationship of a novel Thy-1-,Lyt-1-,Lyt-2+, granulated subpopulation to natural killer cells and mast cells. Eur J Immunol (1985) 1.49
Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes. Infect Immun (1983) 1.43
Protection between different serotypes of bovine rotavirus in gnotobiotic calves: specificity of serum antibody and coproantibody responses. J Clin Microbiol (1987) 1.33
Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J Virol (1989) 1.29
Kinetics, tissue specificity and pathological changes in murine rotavirus infection of mice. J Gen Virol (1986) 1.25
Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes. J Virol (1988) 1.25
Surface and intracellular markers of mouse mesenteric and peripheral lymph node and Peyer's patch cells. J Immunol (1974) 1.23
T-cell-deficient mice display normal recovery from experimental rotavirus infection. J Virol (1986) 1.09
Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients. Am J Med (1984) 1.08
Frequency of herpes simplex virus-specific cytotoxic T lymphocyte precursors in lymph node cells of infected mice. Immunology (1984) 1.07
Avirulent rotavirus infections protect calves from disease with and without inducing high levels of neutralizing antibody. J Gen Virol (1987) 0.98
Rotavirus-specific cytotoxic T lymphocyte response of mice after oral inoculation with candidate rotavirus vaccine strains RRV or WC3. J Infect Dis (1989) 0.79
Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J Virol (1989) 1.29
Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes. J Virol (1988) 1.25
Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J Virol (1991) 1.22
Secretion of a chimeric T-cell receptor-immunoglobulin protein. Proc Natl Acad Sci U S A (1987) 1.17
Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge. J Clin Microbiol (1989) 0.98
The kinetics of generation of influenza-specific cytotoxic T-lymphocyte precursor cells. Cell Immunol (1988) 0.87
Rotavirus-specific protein synthesis is not necessary for recognition of infected cells by virus-specific cytotoxic T lymphocytes. J Virol (1989) 0.79